Parliament’s latest assessment of the state of fundamental rights in the EU identifies numerous concerns and demands member states act in defence of European values. On Thursday, MEPs assessed the state of fundamental values in the EU in 2020 – 2021, identifying areas of concern and proposing ways to protect freedom, equality and the rule […]
Team Europe has delivered €47.7 billion to help the pandemic
Since the outbreak of COVID-19 in early 2020, the EU, EU Member States and European financial institutions, as Team Europe, have disbursed €47.7 billion in support of partner countries in addressing the pandemic and its consequences, delivering on its promises with concrete results. This figure exceeds by far the initial €20 billion Team Europe support […]
ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines
The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) have issued a joint statement providing updated public health considerations on the use of the newly authorised adapted COVID-19 vaccines to support the planning of the autumn and winter vaccination campaigns. The EU has recently extended its arsenal with two new updated vaccines, Comirnaty […]
Commission rallies Member States to prepare for autumn and winter
The Commission is proposing concrete measures to avoid a surge of COVID-19 cases in the upcoming autumn and winter season. The Commission is urging Member States to put the necessary strategies and structures in place, including for COVID-19 vaccination and surveillance, to respond to future outbreaks in a fast and sustained manner. The main aim of […]
First adapted COVID-19 booster vaccines recommended for approval in the EU
EMA’s human medicines committee (CHMP) has recommended authorising two vaccines adapted to provide broader protection against COVID-19. Comirnaty Original/Omicron BA.1 and Spikevax Bivalent Original/Omicron BA.1 are for use in people aged 12 years and above who have received at least primary vaccination against COVID-19. These vaccines are adapted versions of the original vaccines Comirnaty (Pfizer/BioNTech) […]
COVID-19 vaccines: Commission and Moderna delivery schedules
The European Commission and Moderna have reached an agreement to better address Member States needs for COVID-19 vaccines for the late summer and winter period. This will ensure national authorities have access to the vaccines, including variant-adapted vaccines if authorised, at the time they need them for their own vaccination campaigns and to support their […]
Joint Procurement contract HIPRA for Covid-19
HERA, the European Commission’s Health Preparedness and Response Authority, has signed a joint procurement Framework Contract with the company HIPRA HUMAN HEALTH for the supply of their protein COVID-19 vaccine. 14 Member States and countries are participating in this joint procurement, under which they can purchase up to 250 million doses. As the number of cases is […]
EU and World Vision’s COVID-19 response programme enhance resilience and livelihoods of vulnerable communities in Indonesia
The European Union (EU), World Vision Netherlands and Wahana Visi Indonesia held a closing ceremony of their two-year project “Indonesia COVID-19 Pandemic Emergency Responses (I-COPE)”. The project has contributed to limiting the spread of COVID-19 and reducing its impact on vulnerable children and families in Indonesia. The project is implemented in 90 villages in six districts/ […]
ECDC releases publications on COVID-19 vaccination strategies
Following the joint statement from the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) on 11 July 2022, ECDC has released Preliminary public health considerations for COVID-19 vaccination strategies in the second half of 2022. ECDC, in collaboration with the World Health Organization (WHO) Regional Office for Europe, has […]